Results 41 to 50 of about 3,299 (210)

OPTIMIZING EXISTING TOOLS FOR REACHING AN ADEQUATE DISEASE CONTROL IN PATIENTS WITH SPONDYLOARTHRITIS [PDF]

open access: yesRomanian Journal of Rheumatology, 2016
Background/Objective. Disease activity in spondyloarthritis (SpA) is evaluated through conventional scores such as BASDAI or ASDAS. The aim of this study was to determine disease activity in SpA patients under biological therapy with further assessment ...
Claudia Deaconu   +13 more
doaj   +1 more source

Both ASDAS and ADC are associated with spinal mobility in active axial spondyloarthritis: A comparison between early and later disease [PDF]

open access: yes, 2022
Objective: Using diffusion-weighted imaging (DWI)-derived apparent diffusion coefficient (ADC), we aimed to determine the relationship between intensity of spinal inflammation and mobility in patients with axial spondyloarthritis (SpA) in early and later
Ling Ling Ng   +11 more
core   +1 more source

ASDAS is associated with both the extent and intensity of DW-MRI spinal inflammation in active axial spondyloarthritis [PDF]

open access: yes, 2019
Objective: To investigate the relationship between Ankylosing Spondylitis Disease Activity Score (ASDAS) and intensity of spinal inflammation measured by apparent diffusion coefficient (ADC) in MRI in participants with active axial spondyloarthritis (SpA)
Lau, CS   +5 more
core   +1 more source

Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study [PDF]

open access: yes, 2023
Objective: In axial spondyloarthritis (axSpA), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) are recommended for use in treat-to-target (T2T) strategies.
Bolhuis, T.E.   +6 more
core   +2 more sources

Validity of Simplified Ankylosing Spondylitis Disease Activity Scores (SASDAS) in Indian Ankylosing Spondylitis Patients [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Introduction: Ankylosing Spondylitis Disease Activity Score (ASDAS) is a complex score for monitoring disease activity in Ankylosing Spondylitis (AS). Aim: To develop a simplified version of the ASDAS.
NAGMA BANSAL, LALIT DUGGAL, NEERAJ JAIN
doaj   +1 more source

MAPPING FROM THE ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE (ASDAS) TO EQ5D IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS [PDF]

open access: yes, 2020
Background: Clinical studies often omit outcomes that allow the direct estimation of Quality Adjusted Life Years (QALYs) for use in cost effectiveness analyses crucial for informing policy decisions.
Chrysanthou, Georgios; id_orcid   +6 more
core   +1 more source

POS0344 BASDAI CUT-OFFS FOR DISEASE ACTIVITY CORRESPONDING TO ASDAS-ESR CUT-OFFS IN AXIAL SPONDYLARTHRITIS – RESULTS FROM THE EUROSPA COLLABORATION [PDF]

open access: yes, 2023
BackgroundThe Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is often used for classifying patients according to disease activity states.
Michelsen, B.   +24 more
core   +1 more source

Comparison of Ankylosing Spondylitis Disease Activity Score and Bath Ankylosing Spondylitis Disease Activity Index tools in assessment of axial spondyloarthritis activity

open access: yesRheumatology
Axial spondyloarthritis (axSpA) is an inflammatory joint disease, in which the dominant symptom is inflammatory back pain. It affects approximately 1% of the population, with a higher incidence in males.
Katarzyna Małgorzata Wiąk-Walerowicz   +1 more
doaj   +1 more source

Disease activity guided stepwise tapering or discontinuation of rhTNFR:Fc, an etanercept biosimilar, in patients with ankylosing spondylitis: a prospective, randomized, open-label, multicentric study

open access: yesTherapeutic Advances in Musculoskeletal Disease, 2020
Background: The aim of this study was to evaluate disease-activity-guided stepwise tapering or discontinuation of rhTNFR:Fc, an etanercept biosimilar, in patients with ankylosing spondylitis (AS) in a prospective, randomized, open-label, multicentric ...
Ting Zhang   +11 more
doaj   +1 more source

Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis

open access: yesRMD Open
Background The Assessment of SpondyloArthritis international Society-European Alliance of Associations for Rheumatology recommendations for axial spondyloarthritis (axSpA) management include patient assessment for biological disease-modifying ...
Sofia Ramiro   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy